These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 32102248)

  • 1. The Inhibitory Roles of Vitamin K in Progression of Vascular Calcification.
    Shioi A; Morioka T; Shoji T; Emoto M
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32102248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients.
    Delanaye P; Krzesinski JM; Warling X; Moonen M; Smelten N; Médart L; Pottel H; Cavalier E
    BMC Nephrol; 2014 Sep; 15():145. PubMed ID: 25190488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease.
    van den Heuvel EG; van Schoor NM; Lips P; Magdeleyns EJ; Deeg DJ; Vermeer C; den Heijer M
    Maturitas; 2014 Feb; 77(2):137-41. PubMed ID: 24210635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.
    Westenfeld R; Krueger T; Schlieper G; Cranenburg EC; Magdeleyns EJ; Heidenreich S; Holzmann S; Vermeer C; Jahnen-Dechent W; Ketteler M; Floege J; Schurgers LJ
    Am J Kidney Dis; 2012 Feb; 59(2):186-95. PubMed ID: 22169620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic and Vascular Vitamin K Status in Patients with High Cardiovascular Risk.
    Rapp N; Brandenburg VM; Kaesler N; Bakker SJL; Stöhr R; Schuh A; Evenepoel P; Schurgers LJ
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women.
    Dalmeijer GW; van der Schouw YT; Vermeer C; Magdeleyns EJ; Schurgers LJ; Beulens JW
    J Nutr Biochem; 2013 Apr; 24(4):624-8. PubMed ID: 22819559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncarboxylated matrix Gla-protein: A biomarker of vitamin K status and cardiovascular risk.
    Jespersen T; Møllehave LT; Thuesen BH; Skaaby T; Rossing P; Toft U; Jørgensen NR; Corfixen BL; Jakobsen J; Frimodt-Møller M; Linneberg A
    Clin Biochem; 2020 Sep; 83():49-56. PubMed ID: 32422228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vitamin K in vascular calcification of patients with chronic kidney disease.
    Wuyts J; Dhondt A
    Acta Clin Belg; 2016 Dec; 71(6):462-467. PubMed ID: 27254816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease.
    Jaminon AMG; Dai L; Qureshi AR; Evenepoel P; Ripsweden J; Söderberg M; Witasp A; Olauson H; Schurgers LJ; Stenvinkel P
    Sci Rep; 2020 Apr; 10(1):6586. PubMed ID: 32313061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein.
    Liabeuf S; Bourron O; Olivier B; Vemeer C; Theuwissen E; Magdeleyns E; Aubert CE; Brazier M; Mentaverri R; Hartemann A; Massy ZA
    Cardiovasc Diabetol; 2014 Apr; 13():85. PubMed ID: 24762216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K Supplementation for the Prevention of Cardiovascular Disease: Where Is the Evidence? A Systematic Review of Controlled Trials.
    Vlasschaert C; Goss CJ; Pilkey NG; McKeown S; Holden RM
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32977548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.
    Thamratnopkoon S; Susantitaphong P; Tumkosit M; Katavetin P; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S
    Nephron; 2017; 135(3):167-172. PubMed ID: 27951533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactive Matrix Gla-Protein and Arterial Stiffness in Type 2 Diabetes Mellitus.
    Sardana M; Vasim I; Varakantam S; Kewan U; Tariq A; Koppula MR; Syed AA; Beraun M; Drummen NE; Vermeer C; Akers SR; Chirinos JA
    Am J Hypertens; 2017 Feb; 30(2):196-201. PubMed ID: 27927630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K for Vascular Calcification in Kidney Patients: Still Alive and Kicking, but Still a Lot to Learn.
    Neofytou IE; Stamou A; Demopoulos A; Roumeliotis S; Zebekakis P; Liakopoulos V; Stamellou E; Dounousi E
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?
    Roumeliotis S; Roumeliotis A; Dounousi E; Eleftheriadis T; Liakopoulos V
    Curr Vasc Pharmacol; 2021; 19(1):77-90. PubMed ID: 32196451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins, vascular calcification, and vitamin K-dependent proteins: Is there a relation?
    Zhelyazkova-Savova MD; Yotov YT; Nikolova MN; Nazifova-Tasinova NF; Vankova DG; Atanasov AA; Galunska BT
    Kaohsiung J Med Sci; 2021 Jul; 37(7):624-631. PubMed ID: 33634559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of vitamin K in soft-tissue calcification.
    Theuwissen E; Smit E; Vermeer C
    Adv Nutr; 2012 Mar; 3(2):166-73. PubMed ID: 22516724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review.
    Roumeliotis S; Dounousi E; Eleftheriadis T; Liakopoulos V
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease.
    Mayer O; Seidlerová J; Bruthans J; Filipovský J; Timoracká K; Vaněk J; Cerná L; Wohlfahrt P; Cífková R; Theuwissen E; Vermeer C
    Atherosclerosis; 2014 Jul; 235(1):162-8. PubMed ID: 24835435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients.
    Boxma PY; van den Berg E; Geleijnse JM; Laverman GD; Schurgers LJ; Vermeer C; Kema IP; Muskiet FA; Navis G; Bakker SJ; de Borst MH
    PLoS One; 2012; 7(10):e47991. PubMed ID: 23118917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.